Effectiveness And Cost Per Responder With First-Line Biologics For Rheumatoid Arthritis Using A Validated, Claims-Based Algorithm In A Large Us Commercial Health Plan
Abstract
Authors
J. Curtis B. Chastek L. Becker C. Quach D.J. Harrison H. Yun G. Joseph D. Collier